From: miRNAs expression signature potentially associated with lymphatic dissemination in locally advanced prostate cancer
Patients N0
Patients N1
Age (mean)
51–73 (64)
57–73 (64)
PSA (ng/ml)
4–27,6
7,4-18,41
Pathological stage (T)
T3a/3b
Pathological Gleason
6–9
7–9
Surgical margin
negative
Neoadjuvant therapy
no